Therapeutic targeting of the DNA damage mediators CHK1 and Wee1 in neuroblastoma

被引:0
作者
Russell, Mike [1 ]
Levin, Kirill [1 ]
Rader, JulieAnn [1 ]
Toniatti, Carlo [2 ]
Maris, John M. [1 ]
Cole, Kristina A. [1 ]
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Merck Res Labs, Boston, MA USA
关键词
D O I
10.1158/1538-7445.AM2012-1436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1436
引用
收藏
页数:1
相关论文
共 50 条
[11]   Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress [J].
Saini, Priyanka ;
Li, Yizhu ;
Dobbelstein, Matthias .
ONCOTARGET, 2015, 6 (15) :13072-13087
[12]   Chk1 inhibition and Wee1 inhibition combine synergistically to inhibit cellular proliferation [J].
Davies, Kurtis D. ;
Sullivan, Francis ;
von Carlowitz, Ira ;
Le Huerou, Yvan ;
Wallace, Eli ;
Woessner, Richard D. ;
Gross, Stefan .
CANCER RESEARCH, 2011, 71
[13]   WEE1 and CHK1 gene silencing using Polypurine Reverse Hoogsteen Hairpins [J].
Aubets, E. ;
Ciudad, C. J. ;
Noe, V. .
HUMAN GENE THERAPY, 2019, 30 (11) :A64-A64
[14]   Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation [J].
Restelli, Valentina ;
Vagni, Micaela ;
Arribas, Alberto J. ;
Bertoni, Francesco ;
Damia, Giovanna ;
Carrassa, Laura .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) :129-133
[15]   ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells [J].
Ronco, Cyril ;
Martin, Anthony R. ;
Demange, Luc ;
Benhida, Rachid .
MEDCHEMCOMM, 2017, 8 (02) :295-319
[16]   CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo [J].
Chaudhuri, Leena ;
Vincelette, Nicole D. ;
Koh, Brian D. ;
Naylor, Ryan M. ;
Flatten, Karen S. ;
Peterson, Kevin L. ;
McNally, Amanda ;
Gojo, Ivana ;
Karp, Judith E. ;
Mesa, Ruben A. ;
Sproat, Lisa O. ;
Bogenberger, James M. ;
Kaufmann, Scott H. ;
Tibes, Raoul .
HAEMATOLOGICA, 2014, 99 (04) :688-696
[17]   Chk1 is a wee1 kinase in the G(2) DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation [J].
OConnell, MJ ;
Raleigh, JM ;
Verkade, HM ;
Nurse, P .
EMBO JOURNAL, 1997, 16 (03) :545-554
[18]   Combined Inhibition of ChK1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients [J].
Bruyer, Angelique ;
de Boussac, Hugues ;
Martin, Thibaut ;
Kassambara, Alboukadel ;
Robert, Nicolas ;
Cartron, Guillaume ;
Hose, Dirk ;
Seckinger, Anja ;
Pasero, Philippe ;
Moreaux, Jerome .
BLOOD, 2017, 130
[19]   Radiosensitization of HPV-positive HNSCC cells through the inhibition of Chk1 and Wee1 [J].
Busch, C. -J. ;
Kroeger, M. S. ;
Jensen, J. ;
Kriegs, M. ;
Knecht, R. ;
Petersen, C. ;
Rothkamm, K. ;
Rieckmann, T. .
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 :108-108
[20]   ATR/CHK1/WEE1 DEPENDENCY IN SRSF2-MUTATED MDS/AML [J].
Eldfors, Samuli ;
Rai, Sumit ;
Sharma, Vineet ;
Hossan, Tareq ;
Cabrera, Claudia ;
Bertino, Amy ;
Gilbert, Angelique ;
Walter, Matthew ;
Porkka, Kimmo ;
Graubert, Timothy .
EXPERIMENTAL HEMATOLOGY, 2024, 137